Merck & Co. (MRK)
(Delayed Data from NYSE)
$110.71 USD
+0.39 (0.35%)
Updated Jun 9, 2023 04:03 PM ET
After-Market: $110.51 -0.20 (-0.18%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Earnings News For MRK
-
Merck (MRK) Beats on Q1 Earnings and Sales, Ups 2023 View
-
Merck (MRK) Surpasses Q1 Earnings and Revenue Estimates
-
Merck: Q1 Earnings Snapshot
-
Merck (MRK) to Report Q1 Earnings: What's in the Cards?
-
Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for
-
Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints
-
Merck (MRK) Beats Q4 Earnings and Revenue Estimates
-
Merck: Q4 Earnings Snapshot
-
Will Keytruda & Gardasil Aid Merck (MRK) Sales in Q4 Earnings?
-
Merck (MRK) to Report Q4 Earnings: What's in the Cards?
-
Merck (MRK) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Merck (MRK) Beats on Q3 Earnings & Revenues, Ups 2022 View
-
Merck (MRK) Q3 Earnings and Revenues Surpass Estimates
-
Merck: Q3 Earnings Snapshot
-
Merck (MRK) to Report Q3 Earnings: What's in the Cards?
-
Earnings Preview: Merck (MRK) Q3 Earnings Expected to Decline
-
Merck (MRK) Q2 Earnings & Revenues Top, COVID Drug Helps Sales
-
Merck (MRK) Surpasses Q2 Earnings and Revenue Estimates
-
Merck: Q2 Earnings Snapshot
-
Merck (MRK) to Report Q2 Earnings: What's in the Cards?
-
Merck Q2 Preview: Double-Digit Earnings Growth in Store?
-
Merck (MRK) Q1 Earnings & Sales Beat, COVID Drug Adds $3.3B
-
Merck (MRK) Surpasses Q1 Earnings and Revenue Estimates
-
Will Merck (MRK) Beat Expectations This Earnings Season?
-
Merck (MRK) Earnings Expected to Grow: Should You Buy?